Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
BOSTON, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that ...
- OBE022 is ObsEva's potential first-in-class, oral and selective PGF2alpha receptor antagonist for the ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email